Thrombolysis for lower-extremity deep vein thrombosis

Area of Science:

• Vascular Medicine
• Interventional Cardiology
• Thrombosis Research

Background:

• Acute deep vein thrombosis (DVT) management goals include preventing pulmonary embolism and minimizing post-thrombotic syndrome (PTS).
• Preserving venous valve function and restoring unobstructed flow are critical for long-term outcomes.
• Treatment strategies focus on eliminating thrombus and preventing recurrent venous obstruction.

Observation:

• Thrombolytic agents offer early intervention by dissolving deep vein thrombus, potentially protecting against PTS.
• Catheter-directed thrombolysis for lower-extremity DVT is safe and effective in selected patients, according to the National Venous Registry.
• Percutaneous mechanical devices expedite thrombus removal, impacting the efficiency of catheter-directed thrombolysis.

Findings:

• Early and rapid recanalization is believed to preserve valve function, supporting the use of lytic therapy for acute DVT.
• Catheter-directed thrombolysis demonstrates safety and efficacy in specific patient populations.
• Mechanical thrombectomy significantly reduces procedure time and cost for DVT treatment.

Implications:

• Aggressive treatment, including catheter-directed thrombolysis and mechanical thrombectomy, may reduce the risk of PTS and long-term venous sequelae.
• The National Venous Registry provides guidance for selecting patients who would most benefit from these advanced therapies.
• Further research is needed to fully understand the long-term benefits of these interventional approaches for DVT.